Daptomycin as a possible new treatment option for surgical management of Methicillin-Resistant Staphylococcus aureus sternal wound infection after cardiac surgery

Journal of Cardiothoracic Surgery

Volumn 5, Issue 1, 2010, Pages

  Popov, Aron F ^a   Schmitto, Jan D ^a,b   Tirilomis, Theodor ^a   Bireta, Christian ^a   Coskun, Kasim O ^a   Mokashi, Suyog A ^b   Emmert, Alexander ^a   Friedrich, Martin ^a   Wiese, Christoph H ^a   Schoendube, Friedrich A ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DAPTOMYCIN;

AGED; AORTA VALVE; ARTICLE; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART VALVE PROSTHESIS; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; STAPHYLOCOCCUS INFECTION; STERNUM; SURGICAL INFECTION; VACUUM ASSISTED CLOSURE;

AGED; ANTI-BACTERIAL AGENTS; AORTIC VALVE; CORONARY ARTERY BYPASS; DAPTOMYCIN; FEMALE; HEART VALVE PROSTHESIS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NEGATIVE-PRESSURE WOUND THERAPY; STAPHYLOCOCCAL INFECTIONS; STERNUM; SURGICAL WOUND INFECTION;

EID: 77955204063     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-5-57     Document Type: Article

References (17)

1. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002, issued August 2002. Am J Infect Control 2002, 30:458-75. 10.1067/mic.2002.130032, 12461510.
2. Kappstein I, Schulgen G, Fraedrich G, Schlosser V, Schumacher M, Daschner FD. Added hospital stay due to wound infections following cardiac surgery. Thorac Cardiovasc Surg 1992, 40:148-51. 10.1055/s-2007-1020134, 1412382.
3. Sharma M, Berriel-Cass D, Baran J. Sternal surgical-site infection following coronary artery bypass graft: prevalence, microbiology, and complications during a 42-month period. Infect Control Hosp Epidemiol 2004, 25:468-71. 10.1086/502423, 15242193.
4. Sjogren J, Malmsjo M, Gustafsson R, Ingemansson R. Poststernotomy mediastinitis: a review of conventional surgical treatments, vacuum assisted closure therapy and presentation of the Lund University Hospital mediastinitis algorithm. Eur J Cardiothorac Surg 2006, 30:898-905. 10.1016/j.ejcts.2006.09.020, 17056269.
5. Poncelet AJ, Lengele B, Delaere B, Zech F, Glineur D, Funken JC, El Khoury G, Noirhomme P. Algorithm for primary closure in sternal wound infection: A single institution 10-year experience. Eur J Cardiothorac Surg 2008, 33(2):232-38. 10.1016/j.ejcts.2007.11.016, 18082415.
6. Fowler VG, Kaye KS, Simel DL, Cabell CH, McClachlan D, Smith PK, Levin S, Sexton DJ, Reller LB, Corey GR, Oddone EZ. Staphylococcus aureus bacteremia after median sternotomy: clinical utility of blood culture results in the identification of postoperative mediastinitis. Circulation 2003, 108:73-8. 10.1161/01.CIR.0000079105.65762.DB, 12821547.
7. Gårdlund B, Bitkover CY, Vaage J. Postoperative Mediastinitis in cardiac surgery - microbiology and pathogenesis. Eur J Cardiothorac Surg 2002, 21:825-30. 10.1016/S1010-7940(02)00084-2, 12062270.
8. Sakoulas G, Moellering RC, Eliopoulos GM. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy. Clin Infect Dis 2006, 42:40-50.
9. Robert J, Bismuth R, Jarlier V. Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983-2002. J Antimicrob Chemother 2006, 57:506-10. 10.1093/jac/dki486, 16410265.
10. Weigelt J, Itani K, Stevens D, Lau W, Dryden M, Knirsch C, . Linezolid CSSTI Study Group Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother 2005, 49(6):2260-6. 10.1128/AAC.49.6.2260-2266.2005, 1140485, 15917519, Linezolid CSSTI Study Group.
11. Itani KM, Weigelt J, Li JZ, Duttagupta S. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 2005, 26(6):442-8. 10.1016/j.ijantimicag.2005.09.003, 16289514.
12. Steenbergen JN, Alder J, Thorne GM, Tally FP. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J Antimicrob Chemother 2005, 55:283-288. 10.1093/jac/dkh546, 15705644.
13. Fowler VG, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE, . S. aureus Endocarditis and Bacteremia Study Group Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006, 355(7):653-65. 10.1056/NEJMoa053783, 16914701, S. aureus Endocarditis and Bacteremia Study Group.
14. Furuya EY, Lowy FD. Antimicrobial strategies for the prevention and treatment of cardiovascular infections. Curr Opin Pharmacol 2003, 3(5):464-9. 10.1016/j.coph.2003.05.004, 14559089.
15. Marco F, de la Mària CG, Armero Y, Amat E, Soy D, Moreno A, del Río A, Almela M, Mestres CA, Gatell JM, Jiménez de Anta MT, Miró JM, . Hospital Clinic Experimental Endocarditis Study Group Daptomycin is effective in treatment of experimental. endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2008, 52(7):2538-43. 10.1128/AAC.00510-07, 2443906, 18426900, Hospital Clinic Experimental Endocarditis Study Group.
16. Schmitto JD, Popov AF, Sossalla ST, Coskun KO, Mokashi SA, Wintner A, Schoendube FA. Daptomycin for treatment of methicillin-resistant Staphylococcus epidermidis saphenectomy wound infection after coronary artery bypass graft operation (CABG): a case report. J Cardiothorac Surg 2009, 4:47. 10.1186/1749-8090-4-47, 2753312, 19747387.
17. Weis F, Beiras-Fernandez A, Kaczmarek I, Sodian R, Vicol C, Reichart B, Weis M. Daptomycin for eradication of a systemic infection with a methicillin-resistant-Staphylococcus aureus in a biventricular assist device recipient. Ann Thorac Surg 2007, 84(1):269-70. 10.1016/j.athoracsur.2007.02.001, 17588430.